Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

about

Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors.Single-walled carbon nanotube, multi-walled carbon nanotube and Fe2O3 nanoparticles induced mitochondria mediated apoptosis in melanoma cells.

P2860

Q37457568-008BD714-925E-44DD-8CD4-B963413B3010 Q38647983-1D57DBA6-B86D-4708-9E76-D84E01609F10

P2860

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

Item

http://www.wikidata.org/entity/Q26771751

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@ast

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@en

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@nl

type

Item

label

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@ast

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@en

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@nl

prefLabel

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@ast

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@en

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@nl

P1476

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

@en

P2093

Laurent Mortier

http://www.w3.org/2001/XMLSchema#string

P2860

Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology

Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?

Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants

The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation

Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells

Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents

Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation

On the Origin of Cancer Cells

p53 regulates mitochondrial respiration

P304

283145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/283145

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Jerome Kluza

Philippe Marchetti

Pierre Guerreschi

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285656775

http://www.w3.org/2001/XMLSchema#string

P698

26713093

http://www.w3.org/2001/XMLSchema#string

P932

4680051

http://www.w3.org/2001/XMLSchema#string

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

about

P2860

P2860

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932